Report Detail
Global Dasatinib API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4638798 |
- 24 October, 2025 |
- Global |
- 100 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Dasatinib API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the Philadelphia chromosome. Dasatinib is commonly associated with transient elevations in serum aminotransferase levels during treatment, but with only rare instances of clinically apparent acute liver injury.
This report is a detailed and comprehensive analysis for global Dasatinib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dasatinib API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Dasatinib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Dasatinib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Dasatinib API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dasatinib API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dasatinib API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy's Laboratories, ChemWerth Inc, Teva API, Sun Pharmaceutical, Hubei Haosun Pharmaceutical, ALP Pharm, Sichuan Xieli Pharmaceutical, Boryung Pharmaceutical Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dasatinib API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Dasatinib Tablets
Others
Major players covered
Dr. Reddy's Laboratories
ChemWerth Inc
Teva API
Sun Pharmaceutical
Hubei Haosun Pharmaceutical
ALP Pharm
Sichuan Xieli Pharmaceutical
Boryung Pharmaceutical Co., Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dasatinib API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dasatinib API, with price, sales quantity, revenue, and global market share of Dasatinib API from 2020 to 2025.
Chapter 3, the Dasatinib API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dasatinib API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dasatinib API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dasatinib API.
Chapter 14 and 15, to describe Dasatinib API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Dasatinib API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Dasatinib API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Dasatinib Tablets
- 1.4.3 Others
- 1.5 Global Dasatinib API Market Size & Forecast
- 1.5.1 Global Dasatinib API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Dasatinib API Sales Quantity (2020-2031)
- 1.5.3 Global Dasatinib API Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Dr. Reddy's Laboratories
- 2.1.1 Dr. Reddy's Laboratories Details
- 2.1.2 Dr. Reddy's Laboratories Major Business
- 2.1.3 Dr. Reddy's Laboratories Dasatinib API Product and Services
- 2.1.4 Dr. Reddy's Laboratories Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
- 2.2 ChemWerth Inc
- 2.2.1 ChemWerth Inc Details
- 2.2.2 ChemWerth Inc Major Business
- 2.2.3 ChemWerth Inc Dasatinib API Product and Services
- 2.2.4 ChemWerth Inc Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 ChemWerth Inc Recent Developments/Updates
- 2.3 Teva API
- 2.3.1 Teva API Details
- 2.3.2 Teva API Major Business
- 2.3.3 Teva API Dasatinib API Product and Services
- 2.3.4 Teva API Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Teva API Recent Developments/Updates
- 2.4 Sun Pharmaceutical
- 2.4.1 Sun Pharmaceutical Details
- 2.4.2 Sun Pharmaceutical Major Business
- 2.4.3 Sun Pharmaceutical Dasatinib API Product and Services
- 2.4.4 Sun Pharmaceutical Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Sun Pharmaceutical Recent Developments/Updates
- 2.5 Hubei Haosun Pharmaceutical
- 2.5.1 Hubei Haosun Pharmaceutical Details
- 2.5.2 Hubei Haosun Pharmaceutical Major Business
- 2.5.3 Hubei Haosun Pharmaceutical Dasatinib API Product and Services
- 2.5.4 Hubei Haosun Pharmaceutical Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Hubei Haosun Pharmaceutical Recent Developments/Updates
- 2.6 ALP Pharm
- 2.6.1 ALP Pharm Details
- 2.6.2 ALP Pharm Major Business
- 2.6.3 ALP Pharm Dasatinib API Product and Services
- 2.6.4 ALP Pharm Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 ALP Pharm Recent Developments/Updates
- 2.7 Sichuan Xieli Pharmaceutical
- 2.7.1 Sichuan Xieli Pharmaceutical Details
- 2.7.2 Sichuan Xieli Pharmaceutical Major Business
- 2.7.3 Sichuan Xieli Pharmaceutical Dasatinib API Product and Services
- 2.7.4 Sichuan Xieli Pharmaceutical Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Sichuan Xieli Pharmaceutical Recent Developments/Updates
- 2.8 Boryung Pharmaceutical Co., Ltd
- 2.8.1 Boryung Pharmaceutical Co., Ltd Details
- 2.8.2 Boryung Pharmaceutical Co., Ltd Major Business
- 2.8.3 Boryung Pharmaceutical Co., Ltd Dasatinib API Product and Services
- 2.8.4 Boryung Pharmaceutical Co., Ltd Dasatinib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Boryung Pharmaceutical Co., Ltd Recent Developments/Updates
3 Competitive Environment: Dasatinib API by Manufacturer
- 3.1 Global Dasatinib API Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Dasatinib API Revenue by Manufacturer (2020-2025)
- 3.3 Global Dasatinib API Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Dasatinib API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Dasatinib API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Dasatinib API Manufacturer Market Share in 2024
- 3.5 Dasatinib API Market: Overall Company Footprint Analysis
- 3.5.1 Dasatinib API Market: Region Footprint
- 3.5.2 Dasatinib API Market: Company Product Type Footprint
- 3.5.3 Dasatinib API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Dasatinib API Market Size by Region
- 4.1.1 Global Dasatinib API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Dasatinib API Consumption Value by Region (2020-2031)
- 4.1.3 Global Dasatinib API Average Price by Region (2020-2031)
- 4.2 North America Dasatinib API Consumption Value (2020-2031)
- 4.3 Europe Dasatinib API Consumption Value (2020-2031)
- 4.4 Asia-Pacific Dasatinib API Consumption Value (2020-2031)
- 4.5 South America Dasatinib API Consumption Value (2020-2031)
- 4.6 Middle East & Africa Dasatinib API Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Dasatinib API Sales Quantity by Type (2020-2031)
- 5.2 Global Dasatinib API Consumption Value by Type (2020-2031)
- 5.3 Global Dasatinib API Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Dasatinib API Sales Quantity by Application (2020-2031)
- 6.2 Global Dasatinib API Consumption Value by Application (2020-2031)
- 6.3 Global Dasatinib API Average Price by Application (2020-2031)
7 North America
- 7.1 North America Dasatinib API Sales Quantity by Type (2020-2031)
- 7.2 North America Dasatinib API Sales Quantity by Application (2020-2031)
- 7.3 North America Dasatinib API Market Size by Country
- 7.3.1 North America Dasatinib API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Dasatinib API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Dasatinib API Sales Quantity by Type (2020-2031)
- 8.2 Europe Dasatinib API Sales Quantity by Application (2020-2031)
- 8.3 Europe Dasatinib API Market Size by Country
- 8.3.1 Europe Dasatinib API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Dasatinib API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Dasatinib API Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Dasatinib API Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Dasatinib API Market Size by Region
- 9.3.1 Asia-Pacific Dasatinib API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Dasatinib API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Dasatinib API Sales Quantity by Type (2020-2031)
- 10.2 South America Dasatinib API Sales Quantity by Application (2020-2031)
- 10.3 South America Dasatinib API Market Size by Country
- 10.3.1 South America Dasatinib API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Dasatinib API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Dasatinib API Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Dasatinib API Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Dasatinib API Market Size by Country
- 11.3.1 Middle East & Africa Dasatinib API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Dasatinib API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Dasatinib API Market Drivers
- 12.2 Dasatinib API Market Restraints
- 12.3 Dasatinib API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Dasatinib API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Dasatinib API
- 13.3 Dasatinib API Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Dasatinib API Typical Distributors
- 14.3 Dasatinib API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Dasatinib API. Industry analysis & Market Report on Dasatinib API is a syndicated market report, published as Global Dasatinib API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Dasatinib API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
